https://orcid.org/0000-0001-9104-0670
Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Robert Cowan, Alit Stark-Inbar, Liron Rabany, Dagan Harris, Maya Vizel, Alon Ironi, Julio R. Vieira, Michelle Galen & Christina Treppendahl. (2023) Clinical benefits and economic cost-savings of remote electrical neuromodulation (REN) for migraine prevention. Journal of Medical Economics 26:1, pages 656-664.
Read now
Read now
Kelly E. Dunn. (2023) Iteration is not solving the opioid crisis, it’s time for transformation. The American Journal of Drug and Alcohol Abuse 49:2, pages 151-158.
Read now
Read now
Fulton F. Velez, Danmeng Huang, Lorie Mody & Daniel C. Malone. (2022) Five-year budget impact of a prescription digital therapeutic for patients with opioid use disorder. Expert Review of Pharmacoeconomics & Outcomes Research 22:4, pages 599-607.
Read now
Read now
Yuri A. Maricich, Robert Gerwien, Alice Kuo, Daniel C. Malone & Fulton F. Velez. (2021) Real-world use and clinical outcomes after 24 weeks of treatment with a prescription digital therapeutic for opioid use disorder. Hospital Practice 49:5, pages 348-355.
Read now
Read now
Fulton F. Velez, Hilary F. Luderer, Robert Gerwien, Benjamin Parcher, Dylan Mezzio & Daniel C. Malone. (2021) Evaluation of the cost-utility of a prescription digital therapeutic for the treatment of opioid use disorder. Postgraduate Medicine 133:4, pages 421-427.
Read now
Read now
Articles from other publishers (9)
Harrison R Jordan, Sidharth Sahni, Mamun M Ahmed, Joseph E Fares, Binoy V Desai, Christine N Lenchur & Richard T Jermyn. (2023) A Comprehensive Literature Review of Digital Health Interventions in the Treatment of Substance Use Disorder With Special Focus on Mobile Applications. Cureus.
Crossref
Crossref
Philana Phan, Samir Mitragotri & Zongmin Zhao. (2023) Digital therapeutics in the clinic. Bioengineering & Translational Medicine 8:4.
Crossref
Crossref
Nicholas C. Jacobson, Rachel E. Quist, Camilla M. Lee & Lisa A. Marsch. 2023. Digital Therapeutics for Mental Health and Addiction. Digital Therapeutics for Mental Health and Addiction
5
18
.
Nia Harris. 2023. Technology-Assisted Interventions for Substance Use Disorders. Technology-Assisted Interventions for Substance Use Disorders
81
85
.
Hironori Nakagami. (2022) New wave of digital hypertension management for clinical applications. Hypertension Research 45:10, pages 1549-1551.
Crossref
Crossref
Akihiro Nomura, Tomoyuki Tanigawa, Kazuomi Kario & Ataru Igarashi. (2022) Cost-effectiveness of digital therapeutics for essential hypertension. Hypertension Research 45:10, pages 1538-1548.
Crossref
Crossref
Ali Jalali, Philip J. Jeng, Daniel Polsky, Sabrina Poole, Yi-Chien Ku, George E. Woody & Sean M. Murphy. (2022) Cost-effectiveness of extended-release injectable naltrexone among incarcerated persons with opioid use disorder before release from prison versus after release. Journal of Substance Abuse Treatment 141, pages 108835.
Crossref
Crossref
Karen Sandman & Anna Forsythe. 2022. Digital Healthcare in Germany. Digital Healthcare in Germany
97
107
.
Woo Hyung Lee. (2021) Evaluation and Management of Dysphagia Based on Digital Health Technologies. Journal of the Korean Dysphagia Society 11:2, pages 105-110.
Crossref
Crossref